Literature DB >> 24311762

Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation.

Lowie E G W Vanfleteren1, Martijn A Spruit, Miriam T J Groenen, Piet L B Bruijnzeel, Ziad Taib, Erica P A Rutten, Jos Op 't Roodt, Marco A Akkermans, Emiel F M Wouters, Frits M E Franssen.   

Abstract

Clear evidence for an association between systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) is lacking. Moreover, the effects of pulmonary rehabilitation on arterial stiffness are not well studied. We aimed to 1) confirm increased arterial stiffness in COPD; 2) evaluate its correlates including systemic inflammation; and 3) study whether or not it is influenced by pulmonary rehabilitation. Aortic pulse-wave velocity (APWV) was determined in 168 healthy volunteers, and APWV and inflammatory markers were determined in 162 COPD patients during baseline evaluation of a pulmonary rehabilitation programme. A complete post-pulmonary rehabilitation dataset was collected in 129 patients. It was found that APWV was increased in COPD patients when compared with controls, blood pressure and age predicted baseline APWV, and systemic inflammatory markers were not independently related to APWV. Although baseline APWV was predictive for the change in APWV after pulmonary rehabilitation (r= -0.77), on average APWV did not change (10.7 ± 2.7 versus 10.9 ± 2.5 m·s(-1); p=0.339). Arterial stiffness in COPD is not related to systemic inflammation and does not respond to state-of-the-art pulmonary rehabilitation. These results emphasise the complexity of cardiovascular risk and its management in COPD.

Entities:  

Mesh:

Year:  2013        PMID: 24311762     DOI: 10.1183/09031936.00169313

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  22 in total

Review 1.  Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?

Authors:  Filip Jj Triest; Sally J Singh; Lowie Egw Vanfleteren
Journal:  Chron Respir Dis       Date:  2016-04-14       Impact factor: 2.444

2.  Effectiveness of a 4-week rehabilitation program on endothelial function, blood vessel elasticity in patients with chronic obstructive pulmonary disease.

Authors:  Botond Szucs; Mate Petrekanits; Janos Varga
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

3.  Physical inactivity and arterial stiffness in COPD.

Authors:  Noriane A Sievi; Daniel Franzen; Malcolm Kohler; Christian F Clarenbach
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-10

Review 4.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

Review 5.  COPD and exercise: does it make a difference?

Authors:  Martijn A Spruit; Chris Burtin; Patrick De Boever; Daniël Langer; Ioannis Vogiatzis; Emiel F M Wouters; Frits M E Franssen
Journal:  Breathe (Sheff)       Date:  2016-06

Review 6.  From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling.

Authors:  Rebecca L Heise; Patrick A Link; Laszlo Farkas
Journal:  Front Pediatr       Date:  2016-08-17       Impact factor: 3.418

7.  Impaired training-induced adaptation of blood pressure in COPD patients: implication of the muscle capillary bed.

Authors:  Fares Gouzi; Jonathan Maury; François Bughin; Marine Blaquière; Bronia Ayoub; Jacques Mercier; Antonia Perez-Martin; Pascal Pomiès; Maurice Hayot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-22

8.  A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.

Authors:  Surya P Bhatt; Mark T Dransfield; John R Cockcroft; Jie Wang-Jairaj; Dawn A Midwinter; David B Rubin; Catherine A Scott-Wilson; Courtney Crim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-19

9.  Acute phase proteins as prospective risk markers for arterial stiffness: The Malmö Diet and Cancer cohort.

Authors:  Iram Faqir Muhammad; Yan Borné; Gerd Östling; Cecilia Kennbäck; Mikael Gottsäter; Margaretha Persson; Peter M Nilsson; Gunnar Engström
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

10.  Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls.

Authors:  Kiki Waeijen-Smit; Niki L Reynaert; Rosanne J H C G Beijers; Sarah Houben-Wilke; Sami O Simons; Martijn A Spruit; Frits M E Franssen
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.